A multicenter, non-randomized, open label trial of azithromycin sustained release (SR) for the treatment of laryngopharyngitis or tonsillitis or acute bacterial rhinosinusitis in Japan adults

Trial Profile

A multicenter, non-randomized, open label trial of azithromycin sustained release (SR) for the treatment of laryngopharyngitis or tonsillitis or acute bacterial rhinosinusitis in Japan adults

Completed
Phase of Trial: Phase III

Latest Information Update: 15 May 2008

At a glance

  • Drugs Azithromycin (Primary)
  • Indications Bacterial infections; Pharyngitis; Sinusitis; Tonsillitis
  • Focus Therapeutic Use
  • Sponsors Pfizer
  • Most Recent Events

    • 15 May 2008 The expected completion date for this trial is now 1 May 2007.
    • 13 Jun 2007 Status changed from planning to completed.
    • 12 Nov 2006 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top